Tag Archives: Federal Circuit

PTO Issues Notice on Improvement in Patent Application Quality – A Very Modest Proposal

Posted on January 16, 2013 by Warren Woessner

On January 15, 2013, the USPTO released a notice – see link below – requesting comments on its suggestions of ways to “improve the quality of issued patents” by improving the quality of application drafting. There are two brief sections … Continue reading →

Posted in USPTO Practice and Policy | Tagged , , , , , | Leave a comment

Supreme Court Denies Cert. in Sherley v. Sebelius

Posted on January 9, 2013 by Warren Woessner

The pesky worry about a possible Supreme Court review of the ruling by the D.C. Court of Appeals affirming the Circuit Court’s dismissal of a challenge to the 2009 NIH Stem Cell Funding Guidelines – which permitted NIH funding of … Continue reading →

Posted in Stem Cells/Cloning | Tagged , , , , , , , , , , , , | Leave a comment

Top Ten Biotech IP Stories of 2012

Posted on December 28, 2012 by Warren Woessner

I admit, I am a sucker for lists, esp. Top Ten Lists, and a few days ago, sat through a half hour of “local news” wherein the anchors breathlessly related the Top Ten Rhode Island News Stories of 2012. Well, … Continue reading →

Posted in Miscellaneous | Tagged , , , , , , , , , , , | 2 Comments

In re Rosuvastatin Calcium Patent Litigation – Making “Therasense” out of Confusion

Posted on December 20, 2012 by Warren Woessner

Recently, a divided three judge panel sorting out a multi-party Hatch-Waxman suit, ruled that the patentee, Shinonogi, had not committed inequitable conduct in obtaining the patent that was subsequently reissued so as to obtain narrow claims focused on Rosuvastatin, or … Continue reading →

Posted in Inequitable Conduct/Rule 56, Reissue | Tagged , , , , , , , , , , , , , , , , | 1 Comment